Biomerica (NASDAQ:BMRA) Releases Quarterly Earnings Results

Biomerica (NASDAQ:BMRAGet Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.08) EPS for the quarter, reports. Biomerica had a negative return on equity of 69.21% and a negative net margin of 110.44%. The company had revenue of $1.81 million during the quarter.

Biomerica Price Performance

Shares of BMRA opened at $0.34 on Friday. Biomerica has a 1 year low of $0.24 and a 1 year high of $2.13. The stock’s fifty day moving average price is $0.35 and its two-hundred day moving average price is $0.48. The firm has a market cap of $5.70 million, a PE ratio of -0.92 and a beta of -1.11.

Institutional Investors Weigh In On Biomerica

Several large investors have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. increased its stake in shares of Biomerica by 11.8% in the first quarter. Russell Investments Group Ltd. now owns 225,435 shares of the company’s stock worth $188,000 after purchasing an additional 23,872 shares in the last quarter. Fore Capital LLC boosted its holdings in Biomerica by 72.1% in the 1st quarter. Fore Capital LLC now owns 59,680 shares of the company’s stock worth $50,000 after buying an additional 25,000 shares during the period. Finally, Perritt Capital Management Inc bought a new position in Biomerica in the 2nd quarter worth approximately $31,000. Hedge funds and other institutional investors own 22.28% of the company’s stock.

Biomerica Company Profile

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Featured Articles

Earnings History for Biomerica (NASDAQ:BMRA)

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.